Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Anita Asgar

Interventional Cardiology Chicago, IL Medical Doctor

NPI 1588481022 CMS profile 11699606

675 N Saint Clair St Ste 19-100, Chicago, IL 60611

Open in the dashboard

General payments

$85,033

155 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,690 paid to institutions, not to them · program year 2025

Through program year 2025, Anita Asgar of Chicago, IL is reported in the CMS Open Payments database as having received $85,033 across 155 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $30,690 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80,353 136
2024 General $4,679 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anita Asgar
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Anita Asgar were reported at $80,353. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Anita Asgar Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $0 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $0 $1,136 $382–$2,986 $160
2024 $4,679 $1,181 $395–$3,326 $164
2025 $80,353 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Abbott Laboratories $58,656 63 payments
  2. Medtronic, Inc. $15,439 32 payments
  3. Edwards Lifesciences Corporation $7,660 40 payments
  4. W. L. Gore & Associates, Inc. $2,537 5 payments
  5. Boston Scientific Corporation $201 5 payments
  6. Philips Electronics North America Corporation $193 3 payments
  7. Teleflex LLC $177 2 payments
  8. Atricure, Inc. $105 2 payments
  9. Stryker Corporation $47 2 payments
  10. Cordis US Corp. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Consulting Fee $52,766 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,050 7 payments
  3. Travel and Lodging $11,522 47 payments
  4. Food and Beverage $5,564 92 payments
  5. Grant $95 1 payment
  6. Education $35 1 payment
Products named General payments · program years 2024–2025
  1. MITRACLIP $34,954 25 payments
  2. COREVALVE EVOLUT R $15,274 30 payments
  3. NAVITOR Structural Heart $13,253 15 payments
  4. NAVITOR Vascular $8,159 10 payments
  5. TRICLIP $2,291 13 payments
  6. SAPIEN 3 Ultra RESILIA $2,179 8 payments
  7. Product in Development $1,560 1 payment
  8. GORE CARDIOFORM ASD Occluder $669 1 payment
  9. GORE CARDIOFORM Septal Occluder $308 3 payments
  10. PASCAL $231 3 payments
  11. Other $1,084 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

155 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record